Zileuton
CAS 111406-87-2
Visão geral
Zileuton is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes formation, used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names Zyflo and Zyflo CR
A Anant Labs fabrica e fornece impurezas de Zileuton de alta qualidade para o mercado global. Nossas impurezas EP de Zileuton são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Dados Técnicos
CAS111406-87-2
Fórmula Mol.C11H12N2O2S
Peso Mol.236.296 g/mol
IUPAC1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
SMILESCC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
InChIInChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)
Chave InChIMWLSOWXNZPKENC-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Sinônimos
ZILEUTON111406-87-2ZyfloLeutrolZyflo CRZileutonumA-64077N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyureaABBOTT-64077
